New drug tested in fight against recurrent childhood brain cancer
Disease control
Terminated
This study tested an oral drug called CX-4945 in children and young adults whose medulloblastoma, a type of brain tumor, had come back after standard treatment. The main goals were to find the safest and most effective dose for younger children and to see if the drug could shrink…
Phase: PHASE1, PHASE2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC